
Releases
LOTTE Biologics Finalizes Songdo Plant 1 in Record Time
Two years after breaking ground, LOTTE Biologics has secured formal approval to begin operations at its Songdo Bio Campus Plant 1 in Incheon. The rapid completion of this 120,000-liter antibody manufacturing facility marks a critical expansion for the company’s global production capabilities and its integrated CDMO service model.




























